Share This Link

The sudden onset of fever, chills, flank pain, chest tightness, hypotension, and tachycardia shortly after transfusion initiation strongly suggests an acute hemolytic transfusion reaction. This reaction occurs when the recipient’s immune system attacks transfused RBCs, leading to rapid intravascular hemolysis. Early recognition and immediate intervention are critical to prevent renal failure, shock, and death.

Rationale for correct choices:

• Acute hemolytic transfusion reaction: The client’s symptoms, including flank pain, fever, hypotension, tachycardia, and chest tightness occurring within minutes of transfusion, are classic signs of an acute hemolytic reaction. This occurs due to ABO incompatibility or immune-mediated destruction of transfused red blood cells. Hemolysis releases hemoglobin into circulation, which can lead to acute kidney injury and disseminated intravascular coagulation.

• Stop the transfusion and keep IV line open with normal saline: Stopping the transfusion immediately is the most critical intervention to prevent further hemolysis and systemic complications. Maintaining IV access with normal saline allows for administration of emergency medications and supports circulation. This helps preserve renal perfusion and reduces the risk of acute kidney injury from hemoglobin deposition.

• Notify the healthcare provider immediately: Prompt notification is essential because acute hemolytic reactions require urgent medical management, including laboratory testing, supportive care, and possible ICU transfer. The provider must be informed so that additional orders such as IV fluids, diuretics, or vasopressors can be initiated. Early escalation of care improves outcomes and reduces the risk of irreversible organ damage.

• Urine output and urine color: Monitoring urine output and color is essential because hemoglobin released from lysed RBCs can cause hemoglobinuria, leading to dark or cola-colored urine. Reduced urine output may indicate acute kidney injury from tubular obstruction and hemolysis. Early detection of renal compromise allows for timely interventions such as aggressive hydration. This parameter reflects the severity of intravascular hemolysis.

• Temperature changes: Fever is a hallmark of an acute hemolytic transfusion reaction due to immune activation and cytokine release during RBC destruction. Monitoring temperature trends helps evaluate progression or resolution of the reaction. A rising temperature may indicate worsening hemolysis or associated complications. Continuous monitoring is essential to assess response to interventions and detect deterioration early.

Rationale for incorrect choices:

• Circulatory overload transfusion reaction: Circulatory overload presents with hypertension, jugular venous distension, crackles, and pulmonary edema rather than flank pain or hemolysis-related symptoms. This client is hypotensive and febrile, which does not align with fluid overload. The rapid onset of fever and flank pain strongly indicates hemolytic rather than volume-related complications.

• Allergic transfusion reaction: An allergic reaction usually presents with urticaria, pruritus, and possibly mild wheezing, not hypotension, flank pain, or hemoglobinuria. It is typically mediated by hypersensitivity to plasma proteins rather than RBC destruction. The severity and systemic nature of this client’s symptoms indicate a hemolytic process. Allergic reactions are generally less severe and lack organ-related symptoms.

• Septic transfusion reaction: Although fever can occur in septic transfusion reactions, this presents with severe chills, hypotension, and shock but is associated with contaminated blood products and may include rigors and sepsis progression over time. Although some symptoms overlap, flank pain and signs of hemolysis are more specific to acute hemolytic reaction.

• Plan to administer epinephrine: Epinephrine is indicated for severe anaphylactic reactions involving airway compromise, bronchospasm, and cardiovascular collapse due to IgE-mediated hypersensitivity. This client’s presentation is more consistent with an acute hemolytic transfusion reaction rather than anaphylaxis. There are no signs of urticaria, wheezing, or airway obstruction that would justify epinephrine use.

• Insert an indwelling urinary catheter with urometer: Although urine output monitoring is important in suspected hemolysis, inserting a catheter is not an immediate first-line emergency intervention. The priority is to stop the transfusion, maintain IV access, and notify the provider before performing invasive procedures. Catheter insertion may be appropriate after stabilization if strict urine output measurement is needed.

• Administer antihistamine (diphenhydramine) IV: This is appropriate for mild allergic transfusion reactions characterized by itching, rash, or urticaria. In this case, the client has systemic signs such as hypotension, flank pain, fever, and chest tightness, which are indicative of hemolysis rather than a histamine-mediated allergic response. Antihistamines would not prevent or treat intravascular RBC destruction or its complications.

• Blood calcium levels: Calcium levels are not a priority indicator in acute transfusion reactions and are not directly affected in hemolytic reactions. The primary concerns are renal function and evidence of hemoglobin breakdown rather than electrolyte imbalance. Monitoring calcium would not provide useful information in assessing transfusion-related hemolysis.

• Presence of jugular vein distension: Jugular vein distension is associated with fluid overload or heart failure, not hemolytic transfusion reactions. The client is hypotensive and showing signs of shock rather than volume excess. This finding is inconsistent with the current clinical picture.

• Oxygen saturation: Although oxygen saturation can be monitored in any critically ill client, it is not the most specific indicator of hemolytic transfusion reaction progression. The key complications involve hemolysis and renal injury rather than primary respiratory failure. More direct indicators include urine changes and temperature trends.

The infant with Tetralogy of Fallot is showing signs of clinical deterioration, including worsening hypoxia, fever, hypotension, decreased urine output, and increasing lethargy. The infant’s decreasing oxygen saturation, irregular respirations, and poor perfusion suggest worsening tissue oxygenation and possible progression toward shock or hypoxic crisis. In pediatric cardiac conditions, especially cyanotic heart defects, airway, breathing, and circulation take priority, with immediate emphasis on oxygenation and vascular access for emergency management.

Rationale for correct choices:

• Apply 100% oxygen via facemask: Applying high-concentration oxygen is the immediate priority because the infant is experiencing worsening hypoxemia, as evidenced by declining oxygen saturation, cyanosis, and respiratory distress. In Tetralogy of Fallot, oxygen delivery to tissues is already compromised due to right-to-left shunting, and acute illness can further worsen hypoxia. Oxygen administration helps maximize available oxygen in the bloodstream and reduce systemic hypoxic stress.

• Initiate a peripheral IV: Establishing IV access is critical because the infant is showing signs of systemic instability, including hypotension, fever, decreased urine output, and lethargy. IV access allows for rapid administration of fluids, antipyretics, antibiotics if infection is suspected, and emergency medications if deterioration continues. In pediatric emergencies, vascular access is essential for correcting perfusion deficits and supporting circulation.

Rationale for incorrect choices:

• Administer acetaminophen: Although the infant has a fever, antipyretic administration is not the immediate priority in the presence of respiratory distress, hypoxia, and poor perfusion. Fever may be contributing to increased metabolic demand, but correcting oxygenation and circulation takes precedence. Administering acetaminophen does not address the life-threatening hypoxia or potential shock state. It can be considered after stabilization of airway, breathing, and circulation.

• Auscultate breath sounds: Assessment of breath sounds is important but is not a priority intervention at this stage because the infant already shows clear signs of systemic deterioration requiring immediate action. Respiratory assessment provides useful data, but delaying oxygen therapy and vascular access could worsen outcomes. In rapidly deteriorating pediatric patients, treatment interventions take priority over additional assessments once critical instability is identified.

• Reassure the parent: Providing reassurance is important for family-centered care, but it is not a priority in a life-threatening situation involving hypoxia and potential shock. The infant is demonstrating worsening oxygen saturation, hypotension, and decreased responsiveness, which require immediate intervention. While communication with the parent should occur, it must not delay oxygen administration or IV access.

Rheumatic fever and Kawasaki disease are two pediatric inflammatory conditions that can present with fever and systemic manifestations. Rheumatic fever typically follows an untreated or poorly treated group A streptococcal infection and is associated with elevated antistreptolysin O (ASO) titers and migratory joint pain. Kawasaki disease is a vasculitis of medium-sized vessels that presents with prolonged fever, mucocutaneous changes, and extremity involvement such as edema and erythema of hands and feet. Careful interpretation of clinical findings helps distinguish between the two conditions because both can have overlapping systemic inflammatory signs.

Rationale:

• Temperature: Fever is a shared systemic inflammatory response in both conditions. In rheumatic fever, fever occurs due to an autoimmune response following streptococcal infection. In Kawasaki disease, fever is typically persistent and high-grade, lasting more than 5 days. Because both conditions involve systemic inflammation, elevated temperature supports both disease processes.

• Laboratory results: An elevated antistreptolysin O (ASO) titer indicates recent or ongoing group A streptococcal infection. This is a hallmark diagnostic finding for rheumatic fever, which develops as a post-infectious autoimmune complication. Kawasaki disease is not associated with ASO elevation. Therefore, this laboratory finding strongly supports rheumatic fever only.

• Skin findings: Both conditions can present with skin manifestations due to systemic inflammation. Rheumatic fever may cause erythema marginatum, a rash associated with immune-mediated inflammation. Kawasaki disease presents with polymorphous rash involving the trunk and extremities.

• Pain characteristics: Joint pain, particularly in the hands and feet, is more characteristic of rheumatic fever due to migratory polyarthritis caused by immune-mediated inflammation of synovial membranes. The pain typically shifts between joints and is associated with swelling and tenderness. Kawasaki disease may cause irritability but does not typically cause significant migratory joint pain.

• Mucous membranes: Kawasaki disease is characterized by mucocutaneous inflammation, including cracked lips, strawberry tongue, and conjunctival injection. These findings result from vasculitis affecting small and medium blood vessels in mucosal tissues. Rheumatic fever does not typically involve mucous membrane changes.

• Findings on hands and feet: Edema and erythema of the hands and feet are classic early findings of Kawasaki disease due to systemic vasculitis. These extremity changes may later progress to desquamation in the subacute phase. Rheumatic fever does not typically present with peripheral extremity swelling or erythema.